PharmAthene's Series B Round

PharmAthene raised a round of funding on October 11, 2004.

PharmAthene's primary objective is the development of effective countermeasures to a range of biological and chemical threats having potential lethal effects for the military or civilian populations. …

Articles about PharmAthene's Series B Round: